CKD273, a new proteomics classifier assessing CKD and its prognosis - Wikidata - wikimedia - TriplyDB

CKD273, a new proteomics classifier assessing CKD and its prognosis

CKD273, a new proteomics classifier assessing CKD and its prognosis

http://www.wikidata.org/entity/Q34729912

about

Modeling and Classification of Kinetic Patterns of Dynamic Metabolic Biomarkers in Physical Activity Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides Biomarker discovery in mass spectrometry-based urinary proteomics.Urinary biomarkers for the early diagnosis of retinopathy and nephropathy in type 1 diabetes mellitus: a "steady stream" of information using proteomics.Proteomic urinary biomarker approach in renal disease: from discovery to implementation.Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases.Advances in urinary proteome analysis and applications in systems biology.Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.Proteomic biomarkers in kidney disease: issues in development and implementation.Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies.microRNAs in glomerular diseases from pathophysiology to potential treatment target.Molecular disease presentation in diabetic nephropathy.Novel Biomarkers for Renal Diseases? None for the Moment (but One).The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.Make Precision Medicine Work for Chronic Kidney Disease.The long path towards implementation of clinical proteomics: Exemplified based on CKD273.Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.Urinary Proteomics in Predicting Heart Transplantation Outcomes (uPROPHET)-Rationale and database description.Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures!Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population.Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation.Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria.Biomarkers and personalized therapy in chronic kidney diseases.Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker.The urinary proteome as correlate and predictor of renal function in a population study.Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.A urinary proteome-based classifier for the early detection of decline in glomerular filtration.Diagnostic and prognostic tests in systemic lupus erythematosus.Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates.Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.

P2860

Q28387059-7401346B-912C-4FCA-9E25-EC8D0D2560D0 Q33591146-686115E1-42FF-4AEE-A48F-E83280D23936 Q33772238-5DC8BD60-7F10-4D7C-A0B4-4B0F7A9D2F01 Q33985444-CB775E06-E2EF-4341-ACBF-96D35C3303BB Q35054853-92DDF55A-EFA2-46DD-86A6-E52761FA9BFF Q35891553-EBDF63F0-4FFF-4B7A-98C2-4468B358F8E4 Q35903097-B32D86F6-9B89-4EA4-8258-690C1CA6BD8B Q36956324-40A1F085-54B9-420B-80D6-2E4336FF8943 Q37634057-5620DC48-A2DE-47F1-B63F-0F7F399E487E Q38196316-1993C735-EBE7-443D-ACF1-3B33283E9302 Q38222628-93349623-CD3C-4265-BAB1-3009B3A7AF51 Q38269864-1A60430E-3258-4B5D-A79B-28CA848DFB9A Q38340351-CFBDC403-D754-4B1F-BF9E-7FABDAED019F Q38341211-307540A9-E63B-44E3-955C-DAC4F67F3719 Q38384848-3D42D066-92CB-499A-84A2-80E72788FAA1 Q38424330-05962EB0-0394-467B-968B-6A915540054D Q38460161-5FBF18E6-7F14-49EC-8CB6-C340490A2E6C Q38763898-DC883E52-5EF3-42DF-887A-54B74DC0C404 Q38786133-48BD4A18-17C0-414D-85F7-B4DDE23CE903 Q38906256-249BA71A-D27D-48BD-A753-654E20D7D122 Q38961899-6444C8AF-F822-41D1-B42A-FAEC1C33F905 Q38983877-963C0885-3527-4A8C-BF13-293A725F83CD Q39055330-C1100C6C-9336-41EF-96EA-EE2D1379279C Q39094572-9E69BE83-D27C-4A19-A6F0-D36BDE202C06 Q39427234-F3A1344D-D703-4C4C-AA17-52BC85EA6663 Q40053821-62B3C468-7063-4651-AF8C-81D02765FF43 Q41173762-D2510DF9-0C3A-42E3-B3FE-658330B24FA7 Q41190815-4D955C51-B31D-40D5-BF5A-261C38269C91 Q41575826-654BD39F-4079-4539-883E-EC927DA28DF5 Q42176797-785C4B8F-1787-4CAD-8EEF-85BF765FEEDC Q42182524-A90190AB-2C99-42F3-B181-D8AF468FE10C Q42662118-55EB5F3B-2905-43A0-8B98-5415696E9C2F Q43267395-DCCBE219-CA47-4C42-A91C-937B625F18C9 Q43803028-E3978D79-7D65-42BA-84F1-B88F2C87B1B9 Q47094845-F08E9386-E0A2-408B-B909-ED66BC3E68AA Q47694209-BDB97D1A-E016-44D0-BBBD-749818D047F8 Q49037974-87B8E937-157A-4B00-8CA1-BADFD2A5B05D Q49966463-720F6360-812E-4F92-A889-348F529A0E6D Q50639398-BCCCCA03-15FA-4EFE-B481-0CC537FD86CF Q53536253-D9D98F4D-7D93-4AD6-9FE4-60B157FC1A00

P2860

CKD273, a new proteomics classifier assessing CKD and its prognosis

http://www.wikidata.org/entity/Q34729912

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

CKD273, a new proteomics classifier assessing CKD and its prognosis

@ast

CKD273, a new proteomics classifier assessing CKD and its prognosis

@en

CKD273, a new proteomics classifier assessing CKD and its prognosis

@nl

type

label

CKD273, a new proteomics classifier assessing CKD and its prognosis

@ast

CKD273, a new proteomics classifier assessing CKD and its prognosis

@en

CKD273, a new proteomics classifier assessing CKD and its prognosis

@nl

prefLabel

CKD273, a new proteomics classifier assessing CKD and its prognosis

@ast

CKD273, a new proteomics classifier assessing CKD and its prognosis

@en

CKD273, a new proteomics classifier assessing CKD and its prognosis

@nl

P1433

Q34729912-D6C84EF7-9EDA-491F-8F7D-D9F3A2E1A4F8

P1476

Q34729912-1264B079-7D07-44A9-8C92-A4E07C6B7AED

P2093

Q34729912-079E4DAA-432D-4DD0-AF81-50D50477CD02

Q34729912-1ACA481E-E58C-445C-BC6F-114084E24027

Q34729912-4EECD69B-A491-4257-8002-8FD89822E5ED

Q34729912-92E14657-8EF0-4AA3-A85F-3161E00916F7

Q34729912-CD0AAECC-485E-4E35-874E-79FB43650B0A

Q34729912-ED875FFB-C3B2-4DC2-AEAD-DD421B9057B7

Q34729912-FB902621-FDB1-4EA6-B55C-A11FB5E1C80A

P2860

Q34729912-0A480D18-FE00-413B-B70D-B4E0FAD400B0

Q34729912-13674F27-3AEB-4F73-8695-3631F1C24A5F

Q34729912-18BFC694-DB47-4B84-B000-55968835353C

Q34729912-23767CBD-7FEA-4A3B-AB04-B4EB05EC3705

Q34729912-27E61913-D8D4-468E-9B4B-E319E03E61BE

Q34729912-287F2F9F-8CA2-4D83-A183-F86D88F0422C

Q34729912-2CB7A4A9-9226-402B-9E3C-F8B0225953DF

Q34729912-47EAAB86-038B-43BD-8DCE-DB61FCD34B3C

Q34729912-4E8701B8-229E-43FF-A524-0653CEC214E6

Q34729912-56A592E6-57F4-4A95-9706-6683EB4D95D7

P304

Q34729912-00C911B0-9C18-4AFE-B17B-E931552D0AC1

P31

Q34729912-FD682604-A149-4629-B566-64CF06293B3E

P356

Q34729912-7FBC4460-9298-4243-8203-094F292AB203

P407

Q34729912-A0522445-344A-486D-8FCF-892EDEABACB4

P433

Q34729912-79368C0D-9078-4807-A7F0-D0D401DC8365

P478

Q34729912-22A64629-65EA-464F-B191-E7DD02F7D90F

P50

Q34729912-218111AF-7583-4257-AD36-450C7CBA6F3B

Q34729912-557A9AF7-0E97-451E-8194-5D88A0C8170A

Q34729912-80A34879-4AC7-4D3F-A270-2BDC6EB13970

Q34729912-898E2EE9-9929-4760-9348-634F877DCB1A

Q34729912-9BD245B8-EFFE-4F25-A00A-04E1DD0B730D

P577

Q34729912-722C8BC8-64B3-47E4-A26C-32CF6EBFA48D

P5875

Q34729912-59077E4B-549B-412D-91A9-C38C9AD2F0E9

P698

Q34729912-9D751481-6EF5-4AE0-ADE9-0EDE5B79573A

P932

Q34729912-2471B857-B4A2-4CCF-8421-38A1ABE3E91F

P356

JOURNAL.PONE.0062837

P1433

P1476

CKD273, a new proteomics classifier assessing CKD and its prognosis

@en

P2093

Christian Delles

http://www.w3.org/2001/XMLSchema#string

Georges Mourad

http://www.w3.org/2001/XMLSchema#string

Lourdes Osaba

http://www.w3.org/2001/XMLSchema#string

Mohammed Dakna

http://www.w3.org/2001/XMLSchema#string

Nathalie Gayrard

http://www.w3.org/2001/XMLSchema#string

Ulrika Lundin

http://www.w3.org/2001/XMLSchema#string

Ángel Argilés

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis

Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

US Renal Data System 2012 Annual Data Report.

Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry.

Nephropathy in patients with type 2 diabetes mellitus.

Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease.

P304

e62837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0062837

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Christian Delles

Klaus M Weinberger

P577

2013-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236925131

http://www.w3.org/2001/XMLSchema#string

P698

23690958

http://www.w3.org/2001/XMLSchema#string

P932

3653906

http://www.w3.org/2001/XMLSchema#string